ScholarIQanswers from OpenAlex & ORCID
David B. Badesch
ResearcherPublications, citations & collaboration network
David B. Badesch is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David B. Badesch have?
ScholarIQindexed works
David B. Badesch has 298 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David B. Badesch have?
ScholarIQcitation count
David B. Badesch has 42,914 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David B. Badesch?
ScholarIQh-index
David B. Badesch has an h-index of 79 in OpenAlex.
What is the i10-index of David B. Badesch?
ScholarIQi10-index
David B. Badesch has an i10-index of 150 in OpenAlex.
What is the OpenAlex record for David B. Badesch?
ScholarIQopenalex
The OpenAlex for David B. Badesch is on the source record.
What are the most-cited papers on David B. Badesch?
ScholarIQmost cited works
Bosentan Therapy for Pulmonary Arterial Hypertension
Lewis J. Rubin, David B. Badesch, Robyn J. Barst, Nazzareno Galiè, Carol M. Black, Anne Keogh, Tomás Pulido, Adaani Frost, Sébastiên Roux, Isabelle Leconte, Michael J. Landzberg, Gérald Simonneau
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
Robyn J. Barst, Lewis J. Rubin, Walker Long, Michael D. McGoon, Stuart Rich, David B. Badesch, Bertron Μ. Groves, Victor F. Tapson, Robert C. Bourge, Bruce H. Brundage, Spencer K. Koerner, David Langleben, Cesar A. Keller, Srinivas Murali, Barry F. Uretsky, Linda Clayton, Maria M. Jöbsis, Shelmer D. Blackburn, Denise Shortino, James W. Crow
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
David B. Badesch, Victor F. Tapson, Michael D. McGoon, Bruce H. Brundage, Lewis J. Rubin, Fredrick M. Wigley, Stuart Rich, Robyn J. Barst, Pamela S. Barrett, Kenneth M. Kral, Maria M. Jöbsis, James E. Loyd, Srinivas Murali, Adaani Frost, Reda E. Girgis, Robert C. Bourge, David Ralph, C. Gregory Elliott, Nicholas S. Hill, David Langleben, Robert Schilz, Vallerie V. McLaughlin, Ivan M. Robbins, Bertron Μ. Groves, Shelley Shapiro, Thomas A. Medsger, Seán Gaine, Evelyn M. Horn, James C. Decker, Katharine Knobil
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
Vallerie V. McLaughlin, Ronald J. Oudiz, Adaani Frost, Victor F. Tapson, Srinivas Murali, Richard N. Channick, David B. Badesch, Robyn J. Barst, Henry H. Hsu, Lewis J. Rubin
Ambrisentan Therapy for Pulmonary Arterial Hypertension
Nazzareno Galiè, David B. Badesch, Ronald J. Oudiz, Gérald Simonneau, Michael D. McGoon, Anne Keogh, Adaani Frost, Diane Zwicke, Robert Naeije, Shelley Shapiro, Horst Olschewski, Lewis J. Rubin